Dr. Mark is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1500 21st St
Sacramento, CA 95811Phone+1 916-443-3299Fax+1 916-449-5858
Education & Training
- University of WashingtonFellowship, Infectious Disease, 2003 - 2005
- Los Angeles County-Harbor-UCLA Medical CenterResidency, Internal Medicine, 1998 - 2001
- University of California San Francisco School of MedicineClass of 1998
Certifications & Licensure
- CA State Medical License 2000 - 2026
- WA State Medical License 2003 - 2010
- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- 6 citationsThree Phase III Randomized Controlled Trials of Topical Resiquimod 0.01-Percent Gel To Reduce Anogenital Herpes RecurrencesKaren E. Mark, Spotswood L. Spruance, George R. Kinghorn, Stephen L. Sacks, Herbert B. Slade
Antimicrobial Agents and Chemotherapy. 2014-09-01 - 31 citationsRapidly Cleared Episodes of Oral and Anogenital Herpes Simplex Virus Shedding in HIV-Infected AdultsKaren E. Mark, Anna Wald, Amalia Magaret, Stacy Selke, Steven R. Kuntz
Journal of Acquired Immune Deficiency Syndromes. 2010-08-15 - 11 citationsInternet and Email Use Among STD Clinic PatientsKaren E. Mark, Anna Wald, Linda Drolette, Matthew R. Golden
Sexually Transmitted Diseases. 2008-11-01
Press Mentions
- California's Ambitious Campaign to Reduce HIV Infections, AIDS DeathsNovember 7th, 2016
- A Community-Based Study of Barriers to HIV Care InitiationJuly 24th, 2019
- Doula Services in California’s Medi-Cal Program See Increased Reimbursement RatesJanuary 25th, 2024
Grant Support
- Cdph OA 2011-2015 National HIV Behavioral Surveillance System And Hepatitis TestiNational Center For Hiv, Viral Hepatitis, Stds And Tb Prevention2011–2012
- Effect Of Suppressive Therapy On Behavioral Determinants Of HSV-2 TransmissionNational Institute Of Allergy And Infectious Diseases2007–2009
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: